Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing ...

People with chronic kidney disease and type 2 diabetes may face heart disease up to 28 years earlier than others.

The risk for emergently treated hypocalcemia in individuals receiving denosumab peaked at 2 weeks after administration and ...

November is National Diabetes Awareness Month and the American Diabetes Association is reporting that people with diabetes ...

In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment as compared with bisphosphonates among women with osteoporosis in the ...

"This is the first study to show a clear benefit of GLP-1 receptor agonists on kidney failure or end-stage kidney disease ... common medical conditions like type 2 diabetes, overweight or obesity with ...